SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Sanofi (NASDAQ:SNY), in partnership with Vietnam Vaccine JSC (VNVC), officially launched a state-of-the-art vaccine production facility in Vietnam, marking a major step in boosting the country’s pharmaceutical manufacturing capabilities. The new plant is designed to supply vaccines for both domestic distribution and global export, supporting broader public health goals across Asia and beyond.
The inauguration ceremony, held on Tuesday, was attended by French President Emmanuel Macron during his diplomatic visit to the Southeast Asian nation, underscoring the importance of international collaboration in advancing healthcare access.
Strategically located to serve Vietnam’s growing healthcare needs, the facility enhances local vaccine self-sufficiency while contributing to the global vaccine supply chain. It is part of Sanofi’s ongoing effort to expand its footprint in emerging markets and reinforce its role as a global vaccine leader.
The launch comes amid heightened global attention on vaccine access and preparedness following recent pandemics. By leveraging cutting-edge technology and Sanofi’s extensive vaccine expertise, the facility aims to strengthen Vietnam’s position as a regional hub for pharmaceutical innovation and production.
This initiative reflects Sanofi’s commitment to investing in sustainable healthcare infrastructure and VNVC’s mission to improve immunization access across Vietnam. The collaboration also aligns with government goals to attract high-quality foreign investment in biotechnology and life sciences.
With the new facility operational, Sanofi and VNVC are well-positioned to meet growing demand for essential vaccines, not only within Vietnam but across neighboring countries, contributing to improved regional health outcomes.
The opening of this manufacturing site marks a significant milestone in Vietnam’s healthcare development, offering long-term benefits in vaccine accessibility, economic growth, and international cooperation in the pharmaceutical sector.
